Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Vical Incorporated Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 0.399||$ 1.55|
|Low||$ 0.375||$ 0.2808|
The current last sale of $0.399 is 42.09% Higher thanthe 52 week low.
Company Description (as filed with the SEC)
We research and develop biopharmaceutical products, including those based on our patented DNA delivery technologies, for the prevention and treatment of serious or life-threatening diseases. We currently have four active, independent or partnered, development programs in the area of infectious disease comprised of: · An ongoing Phase 3 clinical trial of ASP0113 for prevention of cytomegalovirus, or CMV, reactivation in hematopoietic stem cell transplant recipients and an ongoing Phase 2 clinical trial of ASP0113 for prevention of CMV infection in kidney transplant recipients, both in collaboration with Astellas Pharma Inc., or Astellas. Astellas expects enrollment in the Phase 3 clinical trial to be completed during the third quarter of 2016. ... More ...
Where does VICL fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$-0.1|
|Quarterly EPS Est:||-0.04|